Feb 8, 2024 | News

  • Share :

LONDON, UK— February 8, 2024 — BiostealthAI®, is thrilled to announce its participation in the London Health Accelerator Programme for Social Enterprise operating in London’s health and life sciences sector. Developed in collaboration between MedCity and the School for Social Entrepreneurs, this programme aims to equip participants with essential skills, mentorship, knowledge, and connections to grow and scale their social enterprises while addressing health disparities in underserved communities.

The 10-week intensive programme, funded by the UK government through the UK Shared Prosperity Fund as part of the Boosting Life Sciences Social Economy programme, will cover seven boroughs in London, including Camden, Hackney, Hammersmith and Fulham, Islington, Lambeth, Southwark, and Tower Hamlets.

"We are excited to join this accelerator programme as the sole for-profit company among a cohort of remarkable social enterprises and contribute to improving health outcomes in our community," said Georgios Papanikolaou, COO of BiostealthAI. "This initiative aligns perfectly with our mission to bridge the digital health divide, starting from West London. We look forward to gaining valuable insights, mentorship, and connections that will help us make a meaningful impact."

Participants will engage in a series of in-person and online study sessions covering various topics such as business strategy analysis, navigating the health and life sciences sector, product development, financial resilience, impact assessment, sales and marketing, procurement, and leadership development.

Georgios Papanikolaou further states, "The programme will introduce BiostealthAI to local service leads and decision-makers to allow us to explore collaborations with local Boroughs in extended pilot studies of a new health screening hub within public settings. Our initiative aligns with the NHS Long Term Plan for a ‘population health management’ approach to improve care for patients, utilising diagnostic hubs in primary care and predictive prevention for tailored screening and early diagnosis."

About BiostealthAI

BiostealthAI was established by innovator Israel Gbati and respiratory health advocate Georgios Papanikolaou, in a bid to monitor health 100% silently and continuously, detecting early symptoms of life-threatening ’silent killers’ as they begin to develop. With the emergence of high-processing-power chips, and advanced miniaturised sensor technology the time has arrived for Touchable® technology to enter our lives. Touchables™ are a new generation of medical-grade, health monitoring objects, seamlessly integrated into everyday living, that perform continuous, non-invasive health monitoring, without the need to wear a device, turn it on, put it to charge, or even think about it.